The Virtual-Body Project Reduces Eating Disorder Symptoms Among Young Adult Brazilian Women: A Pilot Study
Abstract
Background/Objectives: Dissonance-based (DB) eating disorder (ED) prevention programs have been showing their efficacy in reducing ED symptoms among adolescents, young adults, and older people. Several meta-analyses showed that the Body Project is the most effective ED prevention program for at-risk women; however, the program presents high costs when delivered in-person and recruitment on a large scale is limited, suggesting the evaluation of its efficacy when delivered virtually. Thus, we investigated the efficacy of the v-Body Project (i.e., a virtual DB ED prevention program) among young adult Brazilian women. Methods: A pilot study delivered the v-Body Project to 85 Brazilian women (Mage = 22.55, SD = 2.07, age range = 18-25). Measures of ED symptoms, body dissatisfaction, the thin ideal internalization, negative affect, self-esteem, and body appreciation were applied at baseline, post-intervention, and at 1-month and 6-months follow-up. Results: Results demonstrated improvements in all outcomes at post-intervention. Large effect sizes were found for ED symptoms, body dissatisfaction, thin-ideal internalization, negative affect, and body appreciation (Cohen's d = 0.74-1.31) and were maintained up to 6-months. A small effect size was identified for self-esteem (Cohen's d = 0.40), while the efficacy was maintained up to 6-months. Conclusions: Results support the efficacy of the v-Body Project up to 6-months, providing a tool with lower costs for participants and the…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.